Stannous mercaptotropine
亚锡巯胺托品
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameStannous mercaptotropine
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesJiangsu Institute Of Nuclear Medicine
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesN/A
Inactive CompaniesJiangsu Institute Of Nuclear Medicine
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A